ELIZABETH COBLENTZ: Open Payments
NPI 1114356458 · RICHMOND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,345 in 92 payments from 18 companies in 2025. Trend: 2023 $1,153 · 2024 $1,563 · 2025 $1,345
Food & beverage: $1,345
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $480 |
| PFIZER INC. | 19 | $195 |
| UCB, Inc. | 1 | $120 |
| Lilly USA, LLC | 4 | $76 |
| JAZZ PHARMACEUTICALS INC. | 3 | $66 |
| LivaNova USA, Inc. | 3 | $65 |
| Neurocrine BioSciences, Inc. | 2 | $55 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Impel Pharmaceuticals LLC | 1 | $31 |
Products named: QULIPTA, NURTEC ODT, Zilbrysq, UBRELVY, EPIDIOLEX, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, ZEPBOUND, INGREZZA.
Industry payments across KY — which companies pay providers there.
